Skip to main content

Choose your location

Current selection

Canada
English
Canada
United States
Asia Regional
Australia
New Zealand
Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Netherlands
Norway
Portugal
Spain
Sweden
Switzerland
United Kingdom

Download

Audience for the document: Share Class: Language of the document:

Download

Share Class: Language of the document:

Change Details

If you need to change your email address please contact us.
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®) and has prepared and presented this report in compliance with the GIPS standards. T. Rowe Price has been independently verified for the twenty four-year period ended June 30, 2020, by KPMG LLP. The verification report is available upon request. A firm that claims compliance with the GIPS standards must establish policies and procedures for complying with all the applicable requirements of the GIPS standards. Verification provides assurance on whether the firm’s policies and procedures related to composite and pooled fund maintenance, as well as the calculation, presentation, and distribution of performance, have been designed in compliance with the GIPS standards and have been implemented on a firm-wide basis. Verification does not provide assurance on the accuracy of any specific performance report.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest

October 2021 / GLOBAL EQUITIES

Staying Disciplined as Equities Confront a Wall of Worry

Lofty valuations in equity markets may not reflect potential risks.

Key Insights

  • Central banks’ aggressive monetary policies have contributed to elevated valuations that appear detached from business fundamentals.
  • Profit margins near or above historical peaks, waning stimulus, and rising inflation create a challenging environment that may favor lower‑beta strategies.
  • We remain disciplined, seeking to take advantage of market dislocations to invest in quality companies at entry prices that we view as compelling.

The historic market rally that took flight amid the coronavirus pandemic was also notable for another reason—the pursuit of short‑term momentum appeared to crowd out the valuation discipline and focus on underlying business fundamentals that we believe are critical considerations for successful long‑run investing.

A plausible case can be made that the conditions could be in place for further strength in equity markets. Many central banks’ policies remain accommodative, while the combination of increased household savings, pent‑up consumer demand, and the potential for a sharp rebound in corporations’ capital expenditures could provide further fuel for economic growth.

While forecasting regime shifts in the market is, at best, inexact, we believe that the prevalence of elevated valuations, the prospect of waning monetary and fiscal stimulus, and the possible risks posed by inflationary pressures could create a challenging environment for investors to navigate. In our view, such a climate would favor selectivity and, potentially, investment strategies that exhibit lower beta, or less correlation to movements in the broader market.

Demanding Valuations and Historically Elevated Margins

Aggressive central bank and government stimulus to address the coronavirus pandemic appear to have engendered significant market dislocations.

Accommodative monetary policies typically increase equities’ relative appeal, as the downward pressure on the yields to maturity offered by fixed income securities tends to push investors toward riskier assets. Meanwhile, a low risk‑free rate of return effectively boosts the present value of a company’s future cash flows, which can encourage market participants to pay higher near‑term valuation multiples for names that are expected, rightly or wrongly, to deliver high levels of growth farther into the future.

Price‑to‑earnings ratios in many markets have climbed to levels that are above the long‑term median, with valuations in the U.S. appearing especially stretched on a historical basis. Compared with forward price‑to‑earnings ratios at the end of 2020, equity valuations in some international markets have moved lower, likely reflecting expectations for stronger earnings growth over the next 12 months as these economies reopen (Figure 1).

Valuations Appear Elevated in Many Markets

(Fig. 1) 12‑month forward price to earnings versus history

Bar chart showing price to earnings versus history of several indexes.

June 30, 2003, to August 31, 2021.
Source: T. Rowe Price analysis using data and analytics provided by FactSet Research Systems, Inc. All rights reserved. See Additional Disclosures.
Actual results will vary.

Meanwhile, the strength of the recent economic recovery, coupled with cost‑saving measures enacted by corporations during the pandemic, has contributed to surging net margins that have approached or exceeded 20‑year highs in some markets (Figure 2).

Corporate Profitability Near or Above Historical Peaks

(Fig. 2) Net profit margins (trailing 12 months)

Line graph showing net profit margins from 2001 until 2021 of S&P 500, MSCI Europe, & MSCI Japan Indexes.

August 31, 2001, to August 31, 2021.
Source: T. Rowe Price analysis using data and analytics provided by FactSet Research Systems, Inc. All rights reserved. See Additional Disclosures.

Sustaining such a high level of profitability and delivering sufficient earnings growth needed to drive strong equity market returns strike us as potentially challenging propositions. We do not believe that the market has priced in this risk and the difficulties that an increasingly complicated macro environment may pose.

Potential Macro Headwinds

We believe that the economic expansion is likely to continue into 2022. However, at these valuation levels, the removal of the extraordinary stimulus deployed by governments and central banks last year could present a headwind for equities, especially names whose valuations appear most detached from business fundamentals after the risk‑on rally. Any stumbles in the transition from government‑supplied stimulus to organic economic growth—always a risk as the highly infectious delta variant contributes to spiking coronavirus case counts around the world—might also dent investor sentiment and the economic recovery.

In key economies, inflation has also surged well beyond the 1% to 2% level that we would consider healthy, potentially weighing on corporate profitability in sectors contending with rising input costs (Figure 3). Higher prices could also weigh on consumer sentiment and affect the pace of the economic recovery.

Surging Inflation Rates

(Fig. 3) Headline consumer price indexes (all items)

Line graph showing year-over-year consumer price indexes from 2016 to 2021 of various indexes

Five years ended August 31, 2021.
Sources: U.S. Bureau of Labor Statistics, EuroStat, and the UK Office for National Statistics via data provided by FactSet Research Systems, Inc. All rights reserved.

The recent wave of coronavirus infections and the lower vaccination rates in some countries could exacerbate supply chain constraints that have contributed to inflation. A prime example is the shortfall in semiconductor production that has affected pricing and productivity in the auto industry and other end markets. At the same time, the resurgent COVID‑19 case count has also extended the mismatch between labor supply and demand that has driven up wages, as some workers are hesitant to seek employment for fear of exposure to the coronavirus and others must stay home to care for unvaccinated children or other vulnerable family members.

The consensus expectation appears to be that recent inflationary pressures associated with the sudden, pandemic‑driven shutdown and subsequent restarting of broad swaths of the economy should prove transitory—that view underpins the Federal Reserve’s and the European Central Bank’s apparent tolerance for above‑target consumer price increases in the near term.

However, we see the possibility that the stickiness of wage gains and the upsurge in coronavirus infections could create a scenario where inflationary pressure may prove more persistent than the consensus view and what equity market valuations suggest.

...conditions could be ripe for equity valuations to rerate lower if inflation were to remain at elevated levels.

In the past, periods of higher inflation have coincided with lower cyclically adjusted price‑to‑earnings (CAPE) ratios,1 suggesting that conditions could be ripe for equity valuations to rerate lower if inflation were to remain at elevated levels (Figure 4). Given the low‑inflation regime of the past few decades, we believe that a reminder of the historical correlation between inflation and equity valuations may be apt in the current environment, especially if the uptrend in consumer prices and business costs were to persist.

Higher Inflation Has Coincided With Lower Valuations

(Fig. 4) PCE price index inflation (all items) versus S&P 500 Index’s Shiller CAPE ratio

Graphic demostrating how inflation has coincided with lower valuations

June 30, 1961, to June 30, 2021.
Past performance is not a reliable indicator of future performance.
Sources: Shiller CAPE ratio data are from Department of Economics, Yale University. Year-over-year change in personal consumption expenditures price index is fromthe U.S. Bureau of Labor Statistics via data provided by FactSet Research Systems, Inc. All rights reserved. (See Additional Disclosures.) Data analysis by T. Rowe Price.
PCE is personal consumption expenditures price index, a measure of U.S. consumer prices.

In such a scenario, we could also see a proliferation of other concerns and uncertainties that would likely roil the markets, including the risk that a central bank might raise interest rates too far, too fast. At the same time, the prolonged period of relatively accommodative monetary policies that followed the 2008–09 financial crisis and, in some instances, higher sovereign debt loads could limit the extent to which certain central banks could raise interest rates to combat inflation.

We will monitor trends in consumer prices and producer costs closely, along with the shape of the yield curve. A flattening or inverted yield curve could signal the risk of stagflation, an undesirable phenomenon characterized by a combination of negligible economic growth, rising inflation, and elevated unemployment. Even the threat of such a scenario, while not our base case, could bode ill for most asset classes.

Selectivity Amid Uncertainty

The prevalence of lofty valuations at a time when corporate profit margins hover at or above long‑term peaks suggests, in our view, that investors generally have focused more on the ascent than the wall of worry that we believe equity markets have been climbing. In our view, equities have not yet priced in the risk that inflation might end up being higher than expected for longer than expected—let alone the second‑order concerns that could follow.

This divergence between equity markets that strike us as priced to perfection and what we regard as an increasingly imperfect—and complicated—macro backdrop could set the stage for more volatility. Selectivity, in our experience, is likely to be critical in this environment. Although we believe that good entry points in quality companies have become harder to find across the board, we view the opportunity set in some international markets as relatively more appealing than the setup in U.S. equities.

This divergence between equity markets that strike us as priced to perfection and what we regard as an increasingly imperfect—and complicated—macro backdrop could set the stage for increased volatility.

We are sticking with our disciplined process, which seeks to balance business quality with what we regard as attractive valuations. We feel that this approach has the potential to help us manage risk as we strive to add value over a full market cycle. To this end, we believe that our rigorous research into individual companies and bottom‑up approach to stock selection should give the strategy exposure to an array of potential upside drivers that are company‑specific and may not hinge on a shift in market regimes to play out.

What We’re Watching Next

Given the range of international markets in which we can invest, we are closely monitoring coronavirus case rates, vaccination programs, and how the resumption of economic activities in these countries is progressing. Other macro-level considerations on our radar screens include inflation rates and yield spreads, with an eye toward how these developments might affect our holdings and the prospective opportunities that could be created. At the same time, we seek to add to our in-depth understanding of individual companies and industries as part of our ongoing due diligence and search for potentially compelling investment ideas.

IMPORTANT INFORMATION

This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, and prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.  

It is not intended for distribution to retail investors in any jurisdiction.

Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to Accredited Investors as defined under National Instrument 45-106. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services.

© 2021 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the bighorn sheep design are, collectively and/or apart, trademarks or registered trademarks of T. Rowe Price Group, Inc.

Previous Article

October 2021 / GLOBAL EQUITIES

How ESG Helps Make Us Better Value Investors
Next Article

October 2021 / GLOBAL ECONOMY

Volatility Looms as Support Is Withdrawn
202110‑1863101

You are now leaving the T. Rowe Price website

T. Rowe Price is not responsible for the content of third party websites, including any performance data contained within them. Past performance is not a reliable indicator of future performance.